Tedizolid Use in Immunocompromised Patients.
作者信息
Pedretti Zachary, Chen Jacqueline, Barnett Susanne
机构信息
is a PharmD candidate, is a PGY-2 Resident, and is a Clinical Pharmacist, all at the William S. Middleton Memorial Veterans Hospital in Madison, Wisconsin. Dr. Barnett is Associate Professor of Pharmacy at the University of Wisconsin in Madison.
出版信息
Fed Pract. 2018 Jul;35(7):8-11.
Abstract
摘要
相似文献
1
Tedizolid Use in Immunocompromised Patients.泰地唑胺在免疫功能低下患者中的应用。
Fed Pract. 2018 Jul;35(7):8-11.
2
New developments in the management of severe skin and deep skin structure infections - focus on tedizolid.严重皮肤及深部皮肤结构感染管理的新进展——聚焦于特地唑胺
Ther Clin Risk Manag. 2015 May 22;11:857-62. doi: 10.2147/TCRM.S64553. eCollection 2015.
3
Pharmacokinetics of Tedizolid and Pseudoephedrine Administered Alone or in Combination in Healthy Volunteers.替加环素与伪麻黄碱单独或联合给药在健康志愿者体内的药代动力学。
J Clin Med. 2018 Jun 14;7(6):150. doi: 10.3390/jcm7060150.
4
In Vitro activities of Tedizolid and comparator antimicrobial agents against clinical isolates of Staphylococcus aureus collected in 12 countries from 2014 to 2016.替加环素与对照抗菌药物针对2014年至2016年在12个国家收集的金黄色葡萄球菌临床分离株的体外活性
Diagn Microbiol Infect Dis. 2017 Oct;89(2):151-157. doi: 10.1016/j.diagmicrobio.2017.07.001. Epub 2017 Jul 8.
5
Pharmacokinetics, Safety, and Tolerability of Tedizolid Phosphate in Elderly Subjects.磷酸泰地唑胺在老年受试者中的药代动力学、安全性和耐受性。
Clin Pharmacol Drug Dev. 2018 Sep;7(7):788-794. doi: 10.1002/cpdd.426. Epub 2018 Jan 10.
6
Tedizolid for treatment of acute bacterial skin and skin structure infections.替考拉宁治疗急性细菌性皮肤及皮肤结构感染。
Expert Rev Anti Infect Ther. 2015;13(9):1051-60. doi: 10.1586/14787210.2015.1073107. Epub 2015 Jul 27.
7
The role of tedizolid in skin and soft tissue infections.替加环素在皮肤和软组织感染中的作用。
Curr Opin Infect Dis. 2018 Apr;31(2):131-140. doi: 10.1097/QCO.0000000000000439.
8
Efficacy and Safety of Tedizolid Phosphate versus Linezolid in a Randomized Phase 3 Trial in Patients with Acute Bacterial Skin and Skin Structure Infection.磷酸替加环素与利奈唑胺治疗急性细菌性皮肤及皮肤结构感染的随机 3 期临床试验的疗效和安全性。
Antimicrob Agents Chemother. 2019 Jun 24;63(7). doi: 10.1128/AAC.02252-18. Print 2019 Jul.
9
Tedizolid and Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections of the Lower Extremity versus Non-Lower-Extremity Infections.替加环素与利奈唑胺治疗下肢急性细菌性皮肤及皮肤结构感染与非下肢感染的比较
J Am Podiatr Med Assoc. 2017 Jul;107(4):264-271. doi: 10.7547/15-218. Epub 2016 Aug 17.
10
Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial.替考拉宁治疗 6 天与利奈唑胺治疗 10 天治疗急性细菌性皮肤和皮肤结构感染（ESTABLISH-2）：一项随机、双盲、III 期、非劣效性试验。
Lancet Infect Dis. 2014 Aug;14(8):696-705. doi: 10.1016/S1473-3099(14)70737-6. Epub 2014 Jun 5.
本文引用的文献
1
Epidemiology, determinants, and management of AIDS cholangiopathy: A review.艾滋病胆管病的流行病学、决定因素和管理：综述。
World J Gastroenterol. 2018 Feb 21;24(7):767-774. doi: 10.3748/wjg.v24.i7.767.
2
Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones.《恶唑烷酮类的临床药代动力学与药效动力学》
Clin Pharmacokinet. 2018 May;57(5):559-575. doi: 10.1007/s40262-017-0601-x.
3
(Re)moving the needle: prospects for all-oral treatment for multidrug-resistant tuberculosis.摒弃注射用药：耐多药结核病全口服治疗的前景
Int J Tuberc Lung Dis. 2016 Dec 1;20(12):18-23. doi: 10.5588/ijtld.16.0039.
4
Myelosuppression-sparing treatment of central nervous system nocardiosis in a multiple myeloma patient utilizing a tedizolid-based regimen: a case report.多发性骨髓瘤患者应用替加环素为基础的方案治疗中枢神经系统奴卡菌病致骨髓抑制：一例报告。
Int J Antimicrob Agents. 2017 Apr;49(4):488-492. doi: 10.1016/j.ijantimicag.2016.11.032. Epub 2017 Feb 8.
5
Prolonged use of tedizolid in a pulmonary non-tuberculous mycobacterial infection after linezolid-induced toxicity.在利奈唑胺引起毒性反应后，在肺部非结核分枝杆菌感染中延长使用特地唑胺。
J Antimicrob Chemother. 2017 Feb;72(2):625-628. doi: 10.1093/jac/dkw484. Epub 2016 Dec 20.
6
Characterization of the haematological profile of 21 days of tedizolid in healthy subjects.健康受试者中替加环素治疗 21 天的血液学特征描述。
J Antimicrob Chemother. 2016 Sep;71(9):2553-8. doi: 10.1093/jac/dkw206. Epub 2016 Jun 17.
7
Alternative clinical indications for novel antibiotics licensed for skin and soft tissue infection?已获许可用于皮肤和软组织感染的新型抗生素的其他临床适应症？
Curr Opin Infect Dis. 2015 Apr;28(2):117-24. doi: 10.1097/QCO.0000000000000142.
8
The tolerability of linezolid in the treatment of nontuberculous mycobacterial disease.利奈唑胺治疗非结核分枝杆菌病的耐受性
Eur Respir J. 2015 Apr;45(4):1177-9. doi: 10.1183/09031936.00169114. Epub 2015 Jan 22.
9
Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial.替考拉宁治疗 6 天与利奈唑胺治疗 10 天治疗急性细菌性皮肤和皮肤结构感染（ESTABLISH-2）：一项随机、双盲、III 期、非劣效性试验。
Lancet Infect Dis. 2014 Aug;14(8):696-705. doi: 10.1016/S1473-3099(14)70737-6. Epub 2014 Jun 5.
10
Impact of granulocytes on the antimicrobial effect of tedizolid in a mouse thigh infection model.粒细胞对替加环素在小鼠大腿感染模型中抗菌作用的影响。
Antimicrob Agents Chemother. 2011 Nov;55(11):5300-5. doi: 10.1128/AAC.00502-11. Epub 2011 Sep 12.
Zotero 插件